PCV89 COST-EFFECTIVENESS OF AN EXTENDED FOUR-WEEK FONDAPARINUX PROPHYLAXIS REGIMEN FOR THE PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS UNDERGOING MAJOR ORTHOPEDIC SURGERY
Nov 1, 2005, 00:00
10.1016/S1098-3015(10)67500-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)67500-6/fulltext
Title :
PCV89 COST-EFFECTIVENESS OF AN EXTENDED FOUR-WEEK FONDAPARINUX PROPHYLAXIS REGIMEN FOR THE PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS UNDERGOING MAJOR ORTHOPEDIC SURGERY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67500-6&doi=10.1016/S1098-3015(10)67500-6
First page :
Section Title :
Open access? :
No
Section Order :
67